ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
November 3, 2025
November 3, 2025
Categories
  • Editorials

Beating the odds: Steven Merlin’s journey through pancreatic cancer and clinical trials

An inspiring interview with a 13-year survivor of stage 4 pancreas cancer
Do you like it?
3 Read more
November 3, 2025
November 3, 2025
Categories
  • Editorials

What a difference patients make: Honoring the impact of cancer clinical trial participants

ECOG-ACRIN’s Trial Results Summaries Project aims to inform participants of study findings and express gratitude for their contributions to cancer research
Do you like it?
0 Read more
November 3, 2025
November 3, 2025
Categories
  • New Trials

Now Enrolling: The EAA241 research study is exploring a new treatment approach for patients with newly diagnosed myeloma and kidney failure

This clinical trial aims to improve results with a set of medicines that will treat myeloma and reverse kidney failure at the same time
Do you like it?
0 Read more
November 3, 2025
Patient and doctor talking over clipboard
November 3, 2025
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s clinical trials for patients with pancreatic conditions

For Pancreatic Cancer Awareness Month, we highlight two actively recruiting clinical trials for patients with pancreatic conditions
Do you like it?
0 Read more
November 3, 2025
Research dictionary entry
November 3, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Fall 2025

The latest discoveries from breast, leukemia, lung, nose/sinus, skin, and throat cancer clinical trials
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}